CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Open-market buy President and CEO bought 10,000 shares at $9.59 ($95,900)
- 4 Open-market buy Director bought 36,281 shares at $8.92 ($323,627)
- 4 Open-market buy Chief Financial Officer bought 12,000 shares at an average $7.03 ($84,380)
- 4 Open-market buy Director bought 213,719 shares at $6.98 ($1,491,759)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 424B2 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 15 of 62 · 1,225 filings